Search research articles
Contact Us
Filters
Showing results (471-480 of 567) with videos related to
Page
of 57
Sort By:
Journal of the American College of Cardiology
|
December 1, 1996
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience
S L Woodfield, C F Lundergan, J S Reiner, et al.
Journal of the American College of Cardiology
|
September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events
S G Goodman, M Cohen, F Bigonzi, et al.
European Heart Journal
|
January 17, 2002
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker
E Ronner, E Boersma, K M Akkerhuis, et al.
Circulation
|
October 10, 1997
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7
R H Christenson, E M Ohman, E J Topol, et al.
Journal of the American College of Cardiology
|
November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries
M G Cohen, C B Granger, E M Ohman, et al.
Journal of the American College of Cardiology
|
December 29, 2000
Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments
A D Auerbach, M B Hamel, R M Califf, et al.
American Heart Journal
|
June 1, 1997
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators
R M Califf, L H Woodlief, F E Harrell, et al.
The American Journal of Cardiology
|
December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries
E M Ohman, P W Armstrong, H D White, et al.
The American Journal of Medicine
|
October 24, 2000
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry
M R Shah, C B Granger, B A Bart, et al.
Journal of the American College of Cardiology
|
January 13, 1998
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries
E B Sgarbossa, S L Pinski, E J Topol, et al.
Page
of 57
Search research articles
Search
Showing results (471-480 of 567) with videos related to
Sort By:
Page
of 57
Journal of the American College of Cardiology
|
December 1, 1996
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience
S L Woodfield, C F Lundergan, J S Reiner, et al.
Journal of the American College of Cardiology
|
September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events
S G Goodman, M Cohen, F Bigonzi, et al.
European Heart Journal
|
January 17, 2002
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker
E Ronner, E Boersma, K M Akkerhuis, et al.
Circulation
|
October 10, 1997
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7
R H Christenson, E M Ohman, E J Topol, et al.
Journal of the American College of Cardiology
|
November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries
M G Cohen, C B Granger, E M Ohman, et al.
Journal of the American College of Cardiology
|
December 29, 2000
Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments
A D Auerbach, M B Hamel, R M Califf, et al.
American Heart Journal
|
June 1, 1997
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators
R M Califf, L H Woodlief, F E Harrell, et al.
The American Journal of Cardiology
|
December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries
E M Ohman, P W Armstrong, H D White, et al.
The American Journal of Medicine
|
October 24, 2000
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry
M R Shah, C B Granger, B A Bart, et al.
Journal of the American College of Cardiology
|
January 13, 1998
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries
E B Sgarbossa, S L Pinski, E J Topol, et al.
Page
of 57